Neuropsychological Performance and Its Predictors in the Early Treatment Phase of Non-CNS Pediatric Cancer

Marisa H Huisman1, Sterre Sanstra1, Daniëlle P A Bos1

  • 1Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

PubMed

Insights

Pediatric cancer patients with non-central nervous system (CNS) cancers showed average performance on neuropsychological tests. However, scores were lower than estimated IQ, indicating potential vulnerabilities, with family psychosocial risk linked to memory deficits.

Area of Science:

  • Pediatric Oncology
  • Neuropsychology
  • Childhood Cancer Survivorship

Background:

  • Pediatric cancer survivors often face long-term neuropsychological challenges.
  • Early-phase neuropsychological performance and predictors in non-central nervous system (CNS) cancers remain understudied.

Purpose of the Study:

  • To describe the early neuropsychological performance of children diagnosed with leukemia, lymphoma, or non-CNS solid tumors.
  • To identify predictors of neuropsychological outcomes in this pediatric cancer population.

Main Methods:

  • Neuropsychological assessments (IQ, attention, memory, processing speed, etc.) were conducted on 104 children (aged 5-18) 4.5 months post-diagnosis.
  • Performance was compared to age-matched norms and individual estimated IQ (EIQ).
  • Multiple regression analyses examined medical factors, developmental vulnerabilities, and family psychosocial risk as predictors.

Main Results:

  • Participants' estimated IQ was above average; most neuropsychological scores were within the average range compared to norms.
  • However, scores on most neuropsychological tests were significantly lower than participants' EIQ.
  • Medical factors and developmental vulnerabilities were not associated with outcomes; family psychosocial risk was linked to memory.

Conclusions:

  • Children with non-CNS cancers exhibit average performance on tests but show deficits relative to their EIQ, suggesting potential vulnerabilities.
  • Family psychosocial risk may impact memory function in the early treatment phase.
  • Longitudinal studies with alternative predictors are needed to understand early neuropsychological difficulties.
Abstract